Informazioni
Non ci sono recensioni
Punto di Riferimento
per Medici e Operatori Sanitari
per Medici e Operatori Sanitari
LIBRERIA STUDIUM
Therapeutic Lipidology
Davidson, Toth, Maki
Editore
Springer
Anno
2021
Pagine
689
ISBN
9783030565169
160,00 €
DA SCONTARE
The second edition of this important book provides an up-to-date and comprehensive overview of clinical lipidology. Brand new chapters focus on recent advances in the field including novel biomarkers and the microbiome, genomics of cardiovascular risks, PCSK9 inhibitors, imaging technologies, and epidemiology of atherosclerotic cardiovascular disease.
The book describes new guidelines, novel therapeutic agents, and changes in the understanding of specific lipoproteins and subclasses with regard to their relationships to cardiovascular disease risk. The second edition contains more than thirty chapters covering such topics as the history of lipidology, lipoprotein metabolism and vascular biology, disorders of lipid metabolism, lifestyle/dietary and pharmacologic management for dyslipidemia, the management of dyslipidemia in certain subgroups (e.g., women, children, older patients) and lipid testing, as well as an examination of other biomarkers and testing procedures related to atherosclerosis and cardiovascular disease.
The second edition of Therapeutic Lipidology is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in lipidology, cardiology, endocrinology, pharmacotherapy, and health promotion and disease prevention.
-
History of Lipidology
Pages 1-9
Gotto, Antonio, Jr. (et al.)
-
Atherogenesis and Vascular Biology
Pages 11-34
Toth, Peter P.
-
Genetic Disorders of Lipoprotein Metabolism
Pages 35-80
Brown, Alan S. (et al.)
-
Cardiovascular Genomics
Pages 81-89
Wilkinson, Michael J.
-
Epidemiology of Atherosclerotic Cardiovascular Disease
Pages 91-105
Hirahatake, Kristin M. (et al.)
-
Comparison of 2018 AHA-ACC Multi-Society Cholesterol Guidelines with 2013 ACC-AHA Cholesterol Guidelines
Pages 107-120
Orringer, Carl E. (et al.)
-
The Low-Density Lipoprotein Cholesterol Hypothesis: An Update
Pages 121-138
Rengarajan, Ronak (et al.)
-
Triglyceride-rich Lipoprotein Cholesterol (Remnant Cholesterol) as a Therapeutic Target for Cardiovascular Disease Risk
Pages 139-158
Nordestgaard, Børge G. (et al.)
-
Medical Nutrition Therapy for Lipid and Lipoprotein Disorders
Pages 159-171
Sapp, Philip A. (et al.)
-
Nutraceuticals and Lipid Management
Pages 173-189
Sachinidis, Alexandros G. (et al.)
-
Pharmacology of Statins
Pages 191-205
Kellick, Kenneth (et al.)
-
Management of Statin Intolerance
Pages 207-218
Bartlomiejczyk, Marcin A. (et al.)
-
Intestinally Active Therapies for Hypercholesterolemia: Ezetimibe, Bile Acid Resins, and Plant Sterols
Pages 219-268
Dayspring, Thomas (et al.)
-
Proprotein Convertase Subtilisin/Kexin Type 9: Functional Role in Lipid Metabolism and Its Therapeutic Inhibition
Pages 269-294
Toth, Peter P.
-
Management of Hypertriglyceridemia (Including Fibrates and n-3 Fatty Acids)
Pages 295-306
Evans, Matthew (et al.)
-
Pathophysiology and Management of Dyslipidemias Associated with Insulin-Resistant States
Pages 307-322
Maki, Kevin C. (et al.)
-
Therapeutic Management of Obesity
Pages 323-339
Bray, George A.
-
High-Density Lipoproteins
Pages 341-361
Darabi, Maryam (et al.)
-
Lipoprotein (a): Principles from Bench to Bedside
Pages 363-381
Koschinsky, Marlys L. (et al.)
-
Management of Homozygous Familial Hypercholesterolemia
Pages 383-404
Santos, Raul D.
-
Lysosomal Acid Lipase Deficiency
Pages 405-416
Parham, Johnathon Seth (et al.)
-
Lipodystrophies
Pages 417-429
Simha, Vinaya (et al.)
-
HIV and Dyslipidemia
Pages 431-466
Malvestutto, Carlos D. (et al.)
-
Cardiovascular Disease in Women: Focus on Lipid Management
Pages 467-487
Morris, Pamela B. (et al.)
-
Management of Dyslipidaemia in the Elderly
Pages 489-505
Hamilton-Craig, Ian R. (et al.)
-
Management of Dyslipidemia in Children
Pages 507-525
Brothers, Julie A. (et al.)
-
Lipoprotein Subfractions in Clinical Practice
Pages 527-536
-
Ion Mobility Lipoprotein Analysis
Pages 537-544
King, Sarah M. (et al.)
-
How ApoB Measurements Could Improve Prevention of Cardiovascular Disease
Pages 545-563
Sniderman, Allan D.
-
C-Reactive Protein and Other Inflammatory Markers in Cardiovascular Disease: Inflammatory Disorders and Atherosclerosis
Pages 565-583
Brandt, Eric J.
-
Coronary Artery Calcium and CT Angiography
Pages 585-603
Almeida, Shone (et al.)
-
The Clinical Use of Ultrasound for Atherosclerosis Imaging
Pages 605-614
Feinstein, Steven (et al.)
-
Emerging Therapies for Regulating Dyslipidaemias and Atherosclerosis
Pages 615-636
Ward, Natalie C. (et al.)
-
The Allied Health Professional’s Role in the Management of Dyslipidemia and Accreditation Council for Clinical Lipidology Certification Program
Pages 637-664
Ross, Joyce L.
-
The American Board of Clinical Lipidology Physician Certification Program
Pages 665-667
DeVille, Christopher W.
